Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Selina Simmons-Duffin

๐Ÿ‘ค Speaker
See mentions of this person in podcasts
387 total appearances

Appearances Over Time

Podcast Appearances

NPR News Now
NPR News: 05-02-2026 11AM EDT

The state argued that remote access undermined their abortion ban.

NPR News Now
NPR News: 05-02-2026 11AM EDT

The Fifth Circuit Court of Appeals agreed and issued a ruling to immediately put back a requirement that people go in person for the medication.

NPR News Now
NPR News: 05-02-2026 11AM EDT

That affects people all over the country, including in states that protect abortion access.

NPR News Now
NPR News: 05-02-2026 11AM EDT

The Reproductive Freedom Alliance, a coalition of 23 governors, wrote in a statement, quote, We are taking immediate action to protect patients and providers in our states, and we will pursue every legislative, executive, and legal avenue available, unquote.

NPR News Now
NPR News: 05-02-2026 11AM EDT

Selena Simmons-Duffin, NPR News.

NPR News Now
NPR News: 05-02-2026 5AM EDT

The case was brought by the state of Louisiana against the Food and Drug Administration.

NPR News Now
NPR News: 05-02-2026 5AM EDT

Their argument centered around the FDA's decision to remove an in-person requirement for patients receiving mifepristone, one of the medications used for abortion and miscarriage management.

NPR News Now
NPR News: 05-02-2026 5AM EDT

A district court judge put the case on hold in April, but a panel on the Fifth Circuit Court of Appeals agreed with Louisiana.

NPR News Now
NPR News: 05-02-2026 5AM EDT

The Fifth Circuit ruling ends telemedicine mifepristone access for the whole country, effective immediately.

NPR News Now
NPR News: 05-02-2026 5AM EDT

The drug makers are expected to appeal to the Supreme Court.

NPR News Now
NPR News: 05-02-2026 5AM EDT

Doctors say mifepristone is safe, that the in-person requirement is medically unnecessary, and that it makes it harder for women to access abortion.

NPR News Now
NPR News: 05-02-2026 5AM EDT

Selena Simmons-Duffin, NPR News, Washington.

NPR News Now
NPR News: 05-01-2026 11PM EDT

The case was brought by the state of Louisiana against the Food and Drug Administration.

NPR News Now
NPR News: 05-01-2026 11PM EDT

Their argument centered around the FDA's decision to remove an in-person requirement for patients receiving mifepristone, one of the medications used for abortion and miscarriage management.

NPR News Now
NPR News: 05-01-2026 11PM EDT

A district court judge put the case on hold in April, but a panel on the Fifth Circuit Court of Appeals agreed with Louisiana.

NPR News Now
NPR News: 05-01-2026 11PM EDT

The Fifth Circuit ruling ends telemedicine mifepristone access for the whole country, effective immediately.

NPR News Now
NPR News: 05-01-2026 11PM EDT

The drug makers are expected to appeal to the Supreme Court.

NPR News Now
NPR News: 05-01-2026 11PM EDT

Doctors say mifepristone is safe, that the in-person requirement is medically unnecessary, and that it makes it harder for women to access abortion.

NPR News Now
NPR News: 05-01-2026 11PM EDT

Selena Simmons-Duffin, NPR News, Washington.

NPR News Now
NPR News: 05-01-2026 5PM EDT

The one big beautiful bill act passed by Republicans in Congress last summer created a federal work requirement for Medicaid.